Patents Assigned to Cureium Therapeutics LLC
  • Patent number: 8647618
    Abstract: A method and composition for treating cancer comprising administering to a patient an effective amount of attenuated Salmonella typhimurium containing a plasmid carrying the coding sequence encoding a truncated human interleukin-2 and optionally an oil containing a high antioxidant concentration.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: February 11, 2014
    Assignee: Cureium Therapeutics LLC
    Inventors: Arnold S. Leonard, Daniel A. Saltzman, Mark J. Mueller